{"company":{"id":1898238,"name":"President & CEO AG","domain":"alliancerm.org","url":"https://alion.io/company/alliancerm"},"section":"news","answer":"President & CEO AG: 23 headlines on record, 0 headlines in the last 90 days.","figures":[{"label":"Headlines","value":"23"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"0"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":22}],"news":[{"date":"2025-06-27","kind":"News","title":"FDA takes major step to ease access to CAR-T therapy","source":"BioPharmaDive","url":"https://biopharmadive.com/news/car-t-rems-fda-ease-requirements-bcma-cd19/751865/"},{"date":"2025-06-20","kind":"News","title":"Gene therapy faces fresh uncertainty as two more top FDA officials depart","source":"BioPharmaDive","url":"https://biopharmadive.com/news/nicole-verdun-rachael-anatol-fda-leave-gene-therapy/751156/"},{"date":"2025-06-10","kind":"News","title":"HHS Secretary Favors Regenerative Medicine Over Traditional Pharma: Blessing And Curse?","source":"Insights","url":"https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/hhs-secretary-favors-regenerative-medicine-over-traditional-pharma-blessing-and-curse-J347KC7XHREKTPMTBX5WTF6AAM/"},{"date":"2025-05-13","kind":"News","title":"Scientific societies call for a moratorium on using CRISPR to create genetically modified children","source":"STAT","url":"https://statnews.com/2025/05/13/scientific-societies-call-for-ten-year-moratorium-on-germline-gene-editing-crispr/"},{"date":"2025-05-06","kind":"News","title":"EU HTA Regulation: 'Stepping Beyond' JCAs May Be Needed For Very Rare Disease Drugs","source":"Insights","url":"https://insights.citeline.com/pink-sheet/conferences/eu-hta-regulation-stepping-beyond-jcas-may-be-needed-for-very-rare-disease-drugs-TRAKH6MLJNADXLUEQJYXRVQBOE/"},{"date":"2025-05-05","kind":"News","title":"What The EMA Can Teach HTA Bodies About Joint Clinical Assessments","source":"Insights","url":"https://insights.citeline.com/pink-sheet/advanced-technologies/what-the-ema-can-teach-hta-bodies-about-joint-clinical-assessments-NNES7MN2EZF5HCFWQOE5IDMPYE/"},{"date":"2025-03-25","kind":"News","title":"Impatient about cell and gene therapy? Progress in biotech is not always linear","source":"STAT","url":"https://statnews.com/2025/03/25/cell-gene-therapies-cgt-biotechnology-alliance-regenerative-medicine/"},{"date":"2025-03-18","kind":"News","title":"Why Cell & Gene Therapy Companies Should Talk with RFK Jr. - TimmermanReport.com","source":"Timmerman Report","url":"https://timmermanreport.com/2025/03/why-cell-gene-therapy-companies-should-talk-with-rfk-jr/"},{"date":"2025-01-13","kind":"News","title":"JPM25: Deals, Summit's bravado and gene therapy headwinds","source":"BioPharmaDive","url":"https://biopharmadive.com/news/jpm-25-pharma-deal-outlook-trump-summit-ivonescimab/737198/"},{"date":"2024-10-14","kind":"News","title":"Decentralized Manufacturing Sponsors Must 'Do Their Homework' To Impress US & EU Regulators","source":"Insights","url":"https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/decentralized-manufacturing-sponsors-must-do-their-homework-to-impress-us-eu-regulators-GEBYLQ7AJNFSBJ5OMSMU5R2TIA/"},{"date":"2024-10-03","kind":"News","title":"Meeting on the Mesa to Highlight Cell and Gene Therapy Opportunities, Challenges","source":"BioSpace","url":"https://biospace.com/business/meeting-on-the-mesa-to-highlight-cell-and-gene-therapy-opportunities-challenges"},{"date":"2024-08-01","kind":"News","title":"Worries Over EU JCAs Push Telethon To Speed Up Gene Therapy Filing Plan","source":"Insights","url":"https://insights.citeline.com/PS155077/Worries-Over-EU-JCAs-Push-Telethon-To-Speed-Up-Gene-Therapy-Filing-Plan/"},{"date":"2024-07-19","kind":"News","title":"Gene Therapy And Accelerated Approval: US FDA Mulls Pooling Data To Shrink Postmarket Studies","source":"Insights","url":"https://insights.citeline.com/PS154999/Gene-Therapy-And-Accelerated-Approval-US-FDA-Mulls-Pooling-Data-To-Shrink-Postmarket-Studies/"},{"date":"2024-06-13","kind":"News","title":"Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried","source":"STAT","url":"https://statnews.com/2024/06/13/europe-drug-reviews-price-hta/"},{"date":"2024-05-28","kind":"News","title":"'Pivotal' Regulation On EU Joint Clinical Assessments Extends Dossier Deadlines","source":"Insights","url":"https://insights.citeline.com/PS154766/Pivotal-Regulation-On-EU-Joint-Clinical-Assessments-Extends-Dossier-Deadlines/"},{"date":"2024-05-28","kind":"News","title":"Joint Clinical Assessments Of ATMPs Add To Ethical Concerns Over Need For Randomized Trials","source":"Insights","url":"https://insights.citeline.com/PS154751/Joint-Clinical-Assessments-Of-ATMPs-Add-To-Ethical-Concerns-Over-Need-For-Randomized-Trials/"},{"date":"2024-04-26","kind":"News","title":"Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials","source":"Insights","url":"https://insights.citeline.com/PS150148/Joint-Clinical-Assessments-EU-Guidance-On-Evidence-May-Be-Flexible-For-ATMPs-And-Single-Arm-Trials/"},{"date":"2024-02-01","kind":"News","title":"Sickle Cell Gene Therapy In Medicaid: CMMI Model As 'Bandwidth Extender' For Less Resourced States","source":"Insights","url":"https://insights.citeline.com/PS149715/Sickle-Cell-Gene-Therapy-In-Medicaid-CMMI-Model-As-Bandwidth-Extender-For-Less-Resourced-States/"},{"date":"2024-01-09","kind":"News","title":"Unanswered questions following reports of secondary malignancies after CAR-T cell therapy","source":"Nature","url":"https://nature.com/articles/s41591-023-02767-w?error=cookies_not_supported&amp;code=2b17b781-1f30-41d8-9b33-80399ef67786"},{"kind":"News","title":"Financial Times","source":"ft.com","url":"https://ft.com/content/c5dbb944-4e7b-4851-ba72-2a07252ec54a"},{"kind":"News","title":"POLITICO Pro","source":"pro.politico.eu","url":"https://pro.politico.eu/news/200769"},{"kind":"News","title":"Fierce Biotech","source":"fiercebiotech.com","url":"https://fiercebiotech.com/research/gene-editing-leaders-call-10-year-suspension-heritable-human-genome-editing"}],"as_of":"2026-11-18","cite":"President & CEO AG, News. Alion, Nov 18, 2026. https://alion.io/company/alliancerm/news","html_url":"https://alion.io/company/alliancerm/news","json_url":"https://alion.io/company/alliancerm/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-18T05:20:07Z"}}